Trial Details

COMPLETED
Basic Information
Clinical ID c1064
Identifier NCT04156984
Trial Title Comparison of Two Different Golimumab Dosing Regimens for Ulcerative Colitis
Trial URL Visit Original Page
Study Information
Study Results

NO

Conditions Ulcerative Colitis
Interventions DRUG: Golimumab Prefilled Syringe
Participant Information
Sponsor David Drobne
City Celje
Country/Region Slovenia
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE4
Time Information
Start Date 2021-04-07
Primary Completion Date 2024-06-18
Completion Date 2024-06-18